Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

Share Price is delayed by 15 minutes
Get Live Data
32.00    -0.75 (-2.29%)
Bid:
31.00
Ask:
33.00
Spread: 2.00 (6.452%)
Market Cap: £57.87m
IKA Live PriceLast checked at - London Stock Exchange

Intraday Ilika Plc Share Chart

Directorate Changes

28 Oct 2014 07:00

RNS Number : 4197V
Ilika plc
28 October 2014
 



Ilika plc

("Ilika" or the "Company")

 

Directorate Changes

 

Ilika (AIM: IKA), the accelerated materials innovation company, announces the appointment of Keith Jackson as Non-Executive Director effective January 2015, and the beginning of succession planning for the role of non-Executive Chairman. Current Non-Executive Chairman Jack Boyer, has indicated to the Board that after 10 years in the position, he intends to stand down from his role.

 

Jack Boyer - Non-Executive Chairman

 

Jack Boyer, having recently celebrated a decade of successful leadership as Non-Executive Chairman of Ilika, will be stepping down from the board. Jack announced his intention to stand down at a time when the share price has reached historic highs following the achievement of a series of significant milestones in the Company's development. Ilika's Senior Independent Director, Professor Sir William Wakeham, has been appointed to lead the succession process.

 

Jack Boyer commented: "I have greatly enjoyed my tenure at Ilika but it is good governance practice to rotate board appointments and this is a timely opportunity to conduct a thorough search process and effect an orderly handover to support the future development of the Company."

 

Commenting on this announcement, Graeme Purdy, CEO added: "Jack's contribution to the team over the past ten years has been first class. He has helped to steer the Company through three rounds of venture finance, its IPO in 2010 and contributed to the progress that has resulted in substantial share price growth since flotation. We respect his decision to move on to other challenges having contributed extensively to the development of Ilika from University spin-out to a globally-respected commercial organisation."

 

Keith Jackson - appointment as Non-Executive

 

In a further move to strengthen the Board, Keith Jackson will be appointed as an additional Non-Executive Director to Ilika's board effective January 2015. Keith is currently the Chief Technology Officer at Meggitt plc, the FTSE 100 engineering group, where he is responsible for technology direction and strategy. Keith was previously Chief Technology Officer of Electrical power and control systems at Rolls Royce, having been owner and Managing Director of Pi Technology, which was acquired by Ford.

 

Keith brings considerable expertise in the industrial commercialisation of control systems to Ilika at a time when the Company is preparing for the roll out of its solid state battery technology for wireless sensor networks. He offers a combination of valuable experience in growing entrepreneurial ventures (Pi Technology) and developing complex systems for industrial deployment (Meggitt and Rolls Royce).

 

On Keith's appointment, Graeme Purdy, Ilika's CEO, commented: "This is a very exciting period for Ilika as a number of the materials we have been developing become commercially mature. Ilika's board has always played an important role in setting strategic direction and we have appointed Keith to strengthen our technology commercialisation experience."

 

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan, Nominated Adviser

 

James Black, Corporate Broking

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Paul Cornelius

Mob: 07827 879 460

 

Regulatory disclosures

 

Keith Jackson, (age 54) has not been a director or partner of a company or partnership during the previous five years.

 

Keith Jackson, holds no shares in the Company and there is no further information to be disclosed under Schedule Two, paragraph (g) and Rule 17 of the AIM Rules Companies.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGGRAUUPCPGM
Date   Source Headline
21st May 20267:00 amRNSIlika Trading Update and Notice of Results
10th Apr 20264:01 pmRNSCollaboration with Brompton Bicycles
18th Mar 20267:00 amRNSPositive Feedback on Safety of Goliath Cells
10th Mar 20267:00 amRNSFirst Commercial Delivery to Cirtec Medical
24th Feb 202610:21 amRNSAward of Share Options
19th Feb 20267:00 amRNS-RIlika at Yellowstone Investor Evening: Replacement
22nd Jan 20267:00 amRNSHalf-year Financial Report
21st Jan 20267:00 amRNSIlika Secures Stereax Electrode Order from Cirtec
18th Dec 20257:00 amRNSInitial Stereax M300 Shipments
11th Dec 20257:00 amRNSIlika Ships 10Ah Goliath Battery Prototypes
20th Nov 20257:00 amRNSTrading Update & Notice of Half-Year Results
21st Oct 20257:00 amRNSCommissioning Complete for Goliath Pilot Line
1st Oct 202512:00 pmRNSExercise of Options and Total Voting Rights
23rd Sep 20253:43 pmRNSResult of AGM & Award of Executive Share Options
22nd Sep 20257:00 amRNSStart of Primed Solid-State Battery Programme
28th Aug 20257:00 amRNSNotice of AGM and Posting of Annual Report
18th Aug 20257:00 amRNSStereax Battery Milestone at Cirtec Medical
17th Jul 20258:56 amRNSHolding(s) in Company
17th Jul 20257:00 amRNSFinal Results
15th Jul 20257:00 amRNSAward of Government Grant Funding
11th Jun 20252:09 pmRNSNotice of Results
4th Jun 20252:14 pmRNSHolding(s) in Company
3rd Jun 20251:57 pmRNSHolding(s) in Company
28th May 20256:00 pmRNSResult of Oversubscribed Retail Offer
22nd May 20252:16 pmRNSRetail Offer for up to £0.5 million
22nd May 20251:53 pmRNSResult of Placing & Director Subscription
21st May 20255:14 pmRNSProposed Capital Raise
7th May 202510:03 amRNS-RIlika announces 2025 Investor Day
1st May 20257:00 amRNSGoliath P1 Cells Validated by Customer Testing
15th Apr 20257:00 amRNSGoliath Battery Achieves Scale-up Milestone
6th Mar 20257:00 amRNSGoliath Development Progress
27th Feb 20257:00 amRNSAward & Exercise of Share Options
6th Feb 20253:49 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSGoliath Scale-up Progress
21st Jan 20257:00 amRNSHalf-year Results
9th Jan 20257:00 amRNSStereax Equipment Commissioning Completed
19th Dec 20247:00 amRNSAppointment of Nominated Adviser and Sole Broker
22nd Nov 20242:18 pmRNSAIM Rule 17 Schedule 2(g) Update
20th Nov 20247:00 amRNSGoliath D6 milestone reached
15th Nov 20247:00 amRNSTrading Update & Notice of Half-Year Results
10th Oct 20241:49 pmRNSHolding(s) in Company
3rd Oct 20247:00 amRNSFurther Goliath Technical Milestone Achieved
29th Aug 20247:00 amRNSPosting of Annual Report and Notice of AGM
11th Jul 20247:00 amRNSFinal Results
2nd Jul 20247:00 amRNSKey Technology Validation Milestone
1st Jul 20247:00 amRNSNominated Adviser and Joint Broker
31st May 20242:29 pmRNSHolding(s) in Company
29th May 202411:52 amRNSResults of General Meeting Open Offer and TVR
22nd May 20247:00 amRNSKey Goliath Technology Validation Milestone
16th May 20247:00 amRNSTrading Update, Notice of Results & Presentations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.